Which groundbreaking medication's 2013 launch represented a major shift in pharmaceutical pricing strategy by using a subscription-based "Netflix model" for state Medicaid programs?

The pharmaceutical industry employs various pricing strategies when launching new medications. These strategies balance research and development costs, market competition, patient accessibility, and profit margins. How well do you understand the complex pricing decisions behind major drug launches that have shaped the medical landscape? Test your knowledge about one of the most significant pricing strategy shifts in modern pharmaceutical history.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Sovaldi (sofosbuvir) for Hepatitis C
Humira (adalimumab) for autoimmune disorders
Keytruda (pembrolizumab) for cancer treatment
Ozempic (semaglutide) for diabetes management